康缘药业：产品取得注册证

Group 1 - The core point of the article is that Jiangsu Kangyuan Pharmaceutical Co., Ltd. has received a drug registration certificate for its product "Shenpu Granules" from the National Medical Products Administration [2] - The company's revenue composition for the year 2024 is projected to be 99.16% from domestic sales of industrial enterprises and 0.84% from other businesses [2]